Stand 2.April 2009 (Pre-RS)
| (i) Shares of authorized Common Stock | 6,000,000,000 (6 Mrd.) |
| ~ issued and outstanding | 4,821,537,092 (4,8 Mrd.) |
| (ii) Series A Convertible Preferred Stock par value $.001 | 7,700 |
| (iii) June 2008 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 500,000 shares of Common Stock for every $1,000.00 of principal | ca. 3,000,000 (3 Mio.) |
| (iv) April 2009 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 500,000 shares of Common Stock for every $1,000.00 of principal | ca. 6,000,000 (6 Mio.) |
| (v) Shares of authorized Series G Participating Cumulative Preferred Stock, of which no shares were issued and outstanding. | 2,000,000 (2 Mio. |
Authorized but unissued shares will be available for issuance, and we may issue such shares in the future. If we issue additional shares, the ownership interest of holders of Common Stock will be diluted. We will reserve for issuance any authorized but unissued shares of Common Stock that would be made available as a result of the proposed reverse stock split.
http://www.sec.gov/Archives/edgar/data/880643/.../v150996_defa14a.htm
Stand 7.Juli 2009 (immer noch Pre-RS)
Die 10 Millionen USD-Pakete bestehen zu 30% aus Aktien und zu 70% aus Wandelanleihen. Da der Aktienpreis mit 0.002 USD angegeben wurde, müssten nach Adam Ries insgesamt 3,0 Millionen USD / 0.002 USD = 1,5 Milliarden Aktien an die institutionellen Anleger ausgegeben werden, davon heute am 7.Juli ein Drittel also 500 Millionen, der Rest innerhalb der nächsten 30 Tage.
Wie sieht das nun in der Tabelle aus? Korrigiert mich, aber diese 500 Millionen müssten meiner Meinung nach auf "~ issued and outstanding" addiert werden.
Die restlichen 1 Milliarde Aktien können entsprechend erst nach dem Reverse Split ausgegeben werden, d.h. der kommt auf jeden Fall in den nächsten 30 Tagen. Warum der Deal in zwei Stufen mit einem RS dazwischen durchgezogen wird, ist mir (noch) schleierhaft.
| (i) Shares of authorized Common Stock | 6,000,000,000 (6 Mrd.) |
| ~ issued and outstanding | 5,321,537,092 (5,3 Mrd.) |
| (ii) Series A Convertible Preferred Stock par value $.001 | 7,700 |
| (iii) June 2008 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 500,000 shares of Common Stock for every $1,000.00 of principal | ca. 3,000,000 (3 Mio.) |
| (iv) April 2009 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 500,000 shares of Common Stock for every $1,000.00 of principal | ca. 6,000,000 (6 Mio.) |
| Unsecured Subordinate Convertible Notes convertible into shares of Genta common stock at a conversion rate of 500,000 shares of common stock for every $1,000.00 of principal | ??? |
| (v) Shares of authorized Series G Participating Cumulative Preferred Stock, of which no shares were issued and outstanding. | 2,000,000 (2 Mio. |
Stand 7.Juli 2009 + (30-x) Tage (Post-RS)
| (i) Shares of authorized Common Stock | 6,000,000,000 (6 Mrd.) |
| ~ issued and outstanding | 106,430,741 (106 Mio.) |
| (ii) Series A Convertible Preferred Stock par value $.001 | 7,700 |
| (iii) June 2008 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 10,000 shares of Common Stock for every $1,000.00 of principal | ca. 3,000,000 (3 Mio.) |
| (iv) April 2009 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 10,000 shares of Common Stock for every $1,000.00 of principal | ca. 6,000,000 (6 Mio.) |
| Unsecured Subordinate Convertible Notes convertible into shares of Genta common stock at a conversion rate of 10,000 shares of common stock for every $1,000.00 of principal | ??? |
| (v) Shares of authorized Series G Participating Cumulative Preferred Stock, of which no shares were issued and outstanding. | 2,000,000 (2 Mio. |
Stand 7.August 2009 (Post-RS, 2.Stufe des Deals)
| (i) Shares of authorized Common Stock | 6,000,000,000 (6 Mrd.) |
| ~ issued and outstanding | 1,106,430,741 (1,1 Mrd.) |
| (ii) Series A Convertible Preferred Stock par value $.001 | 7,700 |
| (iii) June 2008 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 10,000 shares of Common Stock for every $1,000.00 of principal | ca. 3,000,000 (3 Mio.) |
| (iv) April 2009 Senior Convertible Promissory Notes convertible into shares of Common Stock at a conversion rate of 10,000 shares of Common Stock for every $1,000.00 of principal | ca. 6,000,000 (6 Mio.) |
| Unsecured Subordinate Convertible Notes convertible into shares of Genta common stock at a conversion rate of 10,000 shares of common stock for every $1,000.00 of principal | ??? |
| (v) Shares of authorized Series G Participating Cumulative Preferred Stock, of which no shares were issued and outstanding. | 2,000,000 (2 Mio. |
So, das heißt Genta hat ab August 4,9 Milliarden Aktien für die Ausgabe in Zukunft, Bedienung der Optionen bzw. Umwandlung der ganzen Anleihen in Aktien. Die werden die im Falle einer EMEA/FDA-Zulassung auch brauchen :-)
Alle Angaben ohne Gewähr! |
Thread abonnieren
